Abstract

5518Background: AGO-OVAR 16 study investigated PZ, an oral multi-kinase inhibitor of VEGFR-1, -2, -3, PDGFR-α and -β and c-Kit. This study was designed to test efficacy, safety and tolerability of ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call